Skip to content
Home/Companies/Pharma/Acousia Therapeutics
AT

Acousia Therapeutics

Pharma·Germany·Active·8yr hold

Acousia Therapeutics is a biotech company, headquartered in Germany.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns Acousia Therapeutics?

Acousia Therapeutics is currently owned by Creathor Ventures through Creathor Venture Fund IV (2018 vintage), since 2018. Across its history, Acousia Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Creathor Ventures
Most recent investor
Creathor Ventures
Creathor Venture Fund IV · 2018 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Boehringer Ingelheim Venture Fund and Creathor Ventures since 2012.
Co-invest · 2 holders · 2012 · present
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2012 · present · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
MOIC
–
Creathor Ventures
Creathor VenturesActive
2018 · present · Creathor Venture Fund IV · 2018 · Evergreen
MOIC
–

More from Creathor Venture Fund IV

Other portfolio companies in the same fund.

HeyJobs
Active
SoftwareGermany· 2019
lengoo
Active
SoftwareGermany· 2019
Tacalyx
Active
BiotechGermany· 2019
Ledgy
Active
FintechSwitzerland· 2018
Wunderflats
Active
SoftwareGermany· 2018

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings